{
    "root": "31555f81-410c-9a69-e063-6394a90ab705",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Itraconazole",
    "value": "20250327",
    "ingredients": [
        {
            "name": "SUCROSE",
            "code": "C151H8M554"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357"
        },
        {
            "name": "FD&C BLUE NO. 1",
            "code": "H3R47K3TBD"
        },
        {
            "name": "GELATIN, UNSPECIFIED",
            "code": "2G86QN327L"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO"
        },
        {
            "name": "DEXTROSE, UNSPECIFIED FORM",
            "code": "IY9XDZ35W2"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A"
        },
        {
            "name": "POTASSIUM HYDROXIDE",
            "code": "WZH3C48M4T"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "AMMONIA",
            "code": "5138Q19F1X"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "ITRACONAZOLE",
            "code": "304NUG5GF4"
        }
    ],
    "indications": "Itraconazole capsules are indicated for the treatment of the following fungal infections in \n  immunocompromised and non-immunocompromised patients:\n \n                  \n                     Blastomycosis, pulmonary and extrapulmonary\n                     Histoplasmosis, including chronic cavitary pulmonary disease and disseminated, non-meningeal histoplasmosis, and\n                     Aspergillosis, pulmonary and extrapulmonary, in patients who are intolerant of or who are refractory to amphotericin B therapy.\n                  \n                  Specimens for fungal cultures and other relevant laboratory studies (wet mount, histopathology, serology) should be obtained before therapy to isolate and identify causative organisms. Therapy may be instituted before the results of the cultures and other laboratory studies are known; however, once these results become available, antiinfective therapy should be adjusted accordingly.\n                  Itraconazole capsules are also indicated for the treatment of the following fungal infections in \n  non-immunocompromised patients:\n \n                  \n                     Onychomycosis of the toenail, with or without fingernail involvement, due to dermatophytes (tinea unguium), and\n                     Onychomycosis of the fingernail due to dermatophytes (tinea unguium).\n                  \n                  Prior to initiating treatment, appropriate nail specimens for laboratory testing (KOH preparation, fungal culture, or nail biopsy) should be obtained to confirm the diagnosis of onychomycosis (see \n  \n                        CLINICAL PHARMACOLOGY: Special Populations, \n   CONTRAINDICATIONS, \n   WARNINGS, and \n   ADVERSE REACTIONS: Post-marketing Experience\n                     for more information).",
    "contraindications": "Itraconazole capsules should be taken with a full meal to ensure maximal absorption. Itraconazole capsules must be swallowed whole.\n                  Itraconazole capsules are a different preparation than itraconazole oral solution and should not be used interchangeably.",
    "warningsAndPrecautions": "Itraconazole capsules USP, \n  100 mg, are supplied as a hard gelatin capsule filled with white to off-white pellets having “AMNEAL” printed on blue opaque cap and “630” on blue transparent body in black ink.\n \n                  They are available as follows:\n  \nUnit dose packages of 30 (5 x 6) NDC 60687-299-25\n \n                  Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Protect from light and moisture.\n                  Keep out of reach of children.\n                  \n                     FOR YOUR PROTECTION: Do not use if blister is torn or broken.",
    "adverseReactions": null
}